Skip to main
AMSF
AMSF logo

AMERISAFE (AMSF) Stock Forecast & Price Target

AMERISAFE (AMSF) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 20%
Hold 60%
Sell 0%
Strong Sell 0%

Bulls say

AMERISAFE Inc has demonstrated a positive outlook due to a 5% increase in its pricing multiple, reaching 1.57x, alongside a significant improvement in the Effective Loss Cost Multiplier (ELCM), indicating enhanced profitability metrics. The company benefits from a strong policy retention rate of 94%, which, combined with consistent profitability and a strategic focus on high-hazard industries, supports expectations for improving financial returns. Additionally, the upward revision of EPS estimates for 2024 and 2025 reflects management's confidence in ongoing internal sales initiatives and favorable market conditions, positioning AMERISAFE for modest multiple expansion in the future.

Bears say

AMERISAFE has experienced a decline in the reserve cushion over the past year, raising concerns about the potential for reduced return on equity due to slowing reserve gains. The company's CEO has highlighted the risk of accelerating medical costs, which could further strain financial performance amid leveling payroll trends and possible inadequacies in reserves for prior accident years. Additionally, increased competition for policyholders may pressure premium rates, compounded by the anticipated rise in workers' compensation claims frequency linked to economic downturns.

AMERISAFE (AMSF) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMERISAFE and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMERISAFE (AMSF) Forecast

Analysts have given AMERISAFE (AMSF) a Buy based on their latest research and market trends.

According to 5 analysts, AMERISAFE (AMSF) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMERISAFE (AMSF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.